and, to a lesser extent, cigarette smoking are risk factors for a first primary breast cancer. Information on these behaviours at diagnosis may contribute to risk prediction of contralateral breast cancer (CBC) and they are potentially modifiable. The WECARE Study is a large population-based case-control study of women with breast cancer where cases (N 5 1,521) had asynchronous CBC and controls (N 5 2,212), matched on survival time and other factors, had unilateral breast cancer (UBC). Using multivariable conditional logistic regression to estimate rate ratios (RR) and 95% confidence intervals (CI), we examined the risk of CBC in relation to drinking and smoking history at and following first diagnosis. We adjusted for treatment, disease characteristics and other factors. There was some evidence for an association between CBC risk and current drinking or current smoking at the time of first breast cancer diagnosis, but the increased risk occurred primarily among women exposed to both (RR 5 1.62, 95% CI 1.24-2.11). CBC risk was also elevated in women who both smoked and drank alcohol after diagnosis (RR 5 1.54, 95% CI 1.18-1.99). In the subset of women with detailed information on amount consumed, smoking an average of 10 cigarettes per day following diagnosis was also associated with increased CBC risk (RR 5 1.50, 95% CI 1.08-2.08; p-trend 5 0.03). Among women with a diagnosis of breast cancer, information on current drinking and smoking could contribute to the prediction of CBC risk. Women who both drink and smoke may represent a group who merit targeted lifestyle intervention to modify their risk of CBC.
Alcohol drinking and, to a lesser extent, cigarette smoking are risk factors for a first primary breast cancer. Information on these behaviours at diagnosis may contribute to risk prediction of contralateral breast cancer (CBC) and they are potentially modifiable. The WECARE Study is a large population-based case-control study of women with breast cancer where cases (N 5 1,521) had asynchronous CBC and controls (N 5 2,212), matched on survival time and other factors, had unilateral breast cancer (UBC). Using multivariable conditional logistic regression to estimate rate ratios (RR) and 95% confidence intervals (CI), we examined the risk of CBC in relation to drinking and smoking history at and following first diagnosis. We adjusted for treatment, disease characteristics and other factors. There was some evidence for an association between CBC risk and current drinking or current smoking at the time of first breast cancer diagnosis, but the increased risk occurred primarily among women exposed to both (RR 5 1.62, 95% CI 1.24-2.11). CBC risk was also elevated in women who both smoked and drank alcohol after diagnosis (RR 5 1.54, 95% CI 1.18-1.99). In the subset of women with detailed information on amount consumed, smoking an average of 10 cigarettes per day following diagnosis was also associated with increased CBC risk (RR 5 1.50, 95% CI 1.08-2.08; p-trend 5 0.03). Among women with a diagnosis of breast cancer, information on current drinking and smoking could contribute to the prediction of CBC risk. Women who both drink and smoke may represent a group who merit targeted lifestyle intervention to modify their risk of CBC.
Breast cancer is the most common cancer in women worldwide 1 with high survival rates in developed countries. 2 Thus, the population of breast cancer survivors at risk of a second primary cancer is large and increasing. Contralateral breast cancer (CBC) is the most common second primary in this group, 3 and in these women, the risk is higher than the risk of developing a first breast cancer in the general population. 4 Therefore, predicting and reducing CBC risk is an important clinical consideration in breast cancer survivors. Alcohol is a modest, but well established risk factor for first primary breast cancer, with plausible biological mechanisms. 5, 6 There has been greater uncertainty regarding the role of cigarette smoking in first primary breast cancer, but the current weight of evidence suggests that active smoking is a risk factor. 7 Few studies have addressed the potential role of these factors in the risk of CBC and the results have been inconsistent. [8] [9] [10] [11] [12] [13] However, these studies all had one or more of the following limitations: small sample size, limited information on the timing of exposure and limited information on potential confounders such as treatment for the first breast cancer.
Information on alcohol and smoking history at the time of a first diagnosis of breast cancer may be a useful addition to CBC risk prediction tools, in combination with other factors. Smoking and alcohol drinking following an initial diagnosis of breast cancer may influence the risk of a subsequent CBC, offering a potential opportunity for risk modification. Given that these lifestyle factors may change over time, it is important to account for the timing of exposure, considering the potential dual role (risk prediction and risk modification) of these factors.
In our previous analysis of the first phase of the Women's Environmental, Cancer and Radiation Epidemiology (WECARE) Study, we found evidence that any alcohol consumption and longer duration of alcohol consumption up to the time of CBC diagnosis (or equivalent date in controls with unilateral breast cancer (UBC)) was associated with an increased risk of CBC, but the association with smoking was not statistically significant. 12 We now present results from the expanded WECARE Study with a focus on smoking and drinking history at the time of a first diagnosis of breast cancer as a potential predictor of CBC, and smoking and drinking following diagnosis as potential modifiable risk factors for CBC.
Methods

Study population
The WECARE Study is a population-based case-control study of women in which cases have asynchronous CBC and controls have UBC. The study recruitment and data collection occurred in two phases, WECARE I (2001-2004) and WECARE II (2009-2012), using similar study procedures in seven study centres, all of which identified eligible women through population-based cancer registries (Fig. 1) . The five U.S. study centres recruited women from registries that contribute to the NCI SEER Registry program: Seattle, Washington; Iowa; Northern California; Los Angeles County, California and Orange and San Diego Counties, California. Additional recruitment and data collection were conducted in Denmark and in Ontario, Canada. In the current analysis, we combined the data from the two study phases. WECARE Study participants were diagnosed prior to age 55 years, between 1985 and 2008, with a first primary invasive breast cancer (local or regional). Cases were also diagnosed with a second primary CBC (in situ or invasive in WECARE I, invasive only in WECARE II) at least one year later in WECARE I or at least two years later in WECARE II with no intervening cancer diagnosis, other than a nonmelanoma skin cancer or cervical carcinoma in situ. Controls had no history of any other cancer diagnoses except nonmelanoma skin cancer or cervical carcinoma in situ up to the reference date. The reference date for cases was the CBC diagnosis date while for controls it was defined by adding the interval between the first breast cancer and the CBC for the matched case to the date of breast cancer for the control. Cases and controls must also have been living in the same study reporting area at the time of their first breast cancer diagnosis and at the reference date. Additionally, controls must not have undergone prophylactic mastectomy of the contralateral breast. All women had to be alive at the time of contact and able to provide informed consent. Controls were individually matched to cases (1:2 for WECARE I and 1:1 for WECARE II) on year of birth (in 5-year strata), year of diagnosis (in 4-year strata), cancer registry region and race/ethnicity. Matching criteria were selected from potential confounders available in the cancer registries. In WECARE I, cases and controls were further counter-matched based on cancer registry reported radiation treatment such that two members of each case-control trio had received radiation treatment for their first breast cancer diagnosis. Countermatching was not used in WECARE II; the type of matching was taken into account in all statistical analyses (see below).
We identified a total of 2,354 CBC cases and 3,599 UBC controls eligible for inclusion. Of these, 1,521 (65%) cases (145 with DCIS as the diagnosis in the contralateral breast) and 2,212 (61%) controls completed an interview and provided a biospecimen for DNA extraction. All study participants provided written informed consent and the study was approved by local Institutional Review or Research Ethics Boards in North America and by the ethical committee system in Denmark.
Data collection
WECARE Study participants were interviewed by telephone using a structured questionnaire designed to obtain information about events occurring both before the diagnosis of the first primary breast cancer and during the period between diagnosis and reference date. The questionnaire addressed currently known and suspected risk factors for breast cancer, including personal demographics, medical history, cancer family history, menstrual and reproductive history, hormone use, body size, cigarette smoking and alcohol intake. Additionally, medical records including pathology reports and What's new? Do alcohol and smoking contribute to the risk of developing breast cancer . . . a second time? Both are risk factors for first breast cancer, and this study set out to identify their impact on contralateral breast cancer risk. The authors set up a casecontrol study, where cases had developed cancer in both breasts at different times, and controls had developed cancer in only one breast. They found that alcohol use and smoking after first diagnosis did increase the risk of developing cancer in the second breast, and recommending lifestyle changes could reduce their risk.
hospital charts were abstracted to collect detailed treatment information (chemotherapy, hormonal therapy and radiation therapy) for the first primary breast cancer and any recurrences experienced prior to the reference date, and tumour characteristics of the first primary.
In both WECARE Study phases, we collected information on whether the women had ever consumed alcohol regularly (at least one drink per month) or smoked cigarettes regularly (at least one cigarette per day for 6 months or longer) before the reference date, as described previously. 12 We also asked at what age women started, whether they had stopped, and, if so, at what age they had last stopped. In WECARE II, we asked more detailed questions on any changes in smoking or drinking amount, when they occurred and amount consumed after the change was made.
Statistical analysis
We used multivariable conditional logistic regression to estimate rate ratios (RR) and 95% confidence intervals (CI) to assess the relationship between alcohol consumption and/or active cigarette smoking and risk of CBC. Models were adjusted initially only for age at first breast cancer diagnosis (continuous) and then also for previously identified risk factors for CBC, including age at menarche (<13 years, 13 years), number of full-term pregnancies (nulliparous, 1-3, 4), first-degree family history of breast cancer (yes, no), , first tumour histology (lobular, other), first tumour stage (local, regional), first tumour estrogen receptor (ER) status (positive, negative) and chemotherapy treatment (yes, no), hormonal treatment (yes, no) and radiation therapy (yes, no) for the first breast cancer or any recurrences occurring before the reference date. Those with missing information were included in a separate category. In addition, models with alcohol-related variables were adjusted for smoking status and models with smoking-related variables were adjusted for drinking status, with status defined as never, former, current at first diagnosis and any or none after first diagnosis. A log-weight covariate was included in the model to account for the sampling probability of the counter-matching for radiation treatment status used in WECARE I. WECARE II participants (who were not counter-matched) were assigned an offset term of 1. Where relevant, we evaluated trends across all categories considering the ordinal category as continuous. We examined drinking and smoking associations in each study phase (WECARE I and II) separately to confirm that combining the two phases was a reasonable approach. As detailed data on amount consumed were only collected in WECARE II, these analyses were restricted to this study phase (813 CBC cases and 813 UBC controls). A two-sided p value <0.05 was considered statistically significant. Analyses were conducted using R 3.2.4.
We examined drinking and smoking status (current, former vs. never) at the time of the first diagnosis of breast cancer as well as duration of use (<20, 20-<30, 30 years vs. never) up to the first diagnosis, age at starting (<20, 20 years vs. never) and drinking and smoking alone or in combination (ever vs. never and current vs. not current) in the combined WECARE Study. In addition, in WECARE II we considered the average amount consumed (5, <5 drinks per week or 10, <10 cigarettes per day vs. none) as well as amount x duration (pack-years and drink-years in categories based on the median in UBC controls). In the period following, the first diagnosis up to the reference date, any drinking and smoking, separately and in combination, were examined in the combined WECARE Study and average amount consumed was considered in WECARE II only. Finally, we tested interactive terms in the model to assess whether drinking and smoking relationships with CBC differed by ER status or first-degree family history of breast cancer or whether there was an interaction between drinking and smoking.
Results
The distribution of age at first breast cancer diagnosis was similar in study participants and non-participants with 17.5% of the former and 18.5% of the latter younger than 40 years. The study population is described in Table 1 . CBC cases and UBC controls were closely matched on age at diagnosis, age at reference date and time between diagnosis and reference date. Cases were more likely to have a family history of breast cancer. The difference in frequency of radiation treatment is due to the counter-matching design used in WECARE I. The slight differences in distribution of CBC cases and UBC controls by study centre arise because some centres (Los Angeles County and Orange and San Diego Counties) only participated in WECARE I where the control to case ratio was 2:1 and some centres (Northern California and Ontario, Canada) only participated in WECARE II where the ratio was 1:1.
There was limited evidence that alcohol drinking history at the time of first breast cancer diagnosis is associated with CBC risk ( Table 2 ). The association of current drinking with CBC risk was of borderline statistical significance compared to never drinking after adjustment (RR 1.19, 95% CI 1.00-1.42). There were fewer former drinkers than current drinkers and, although the RR for former drinking was similar, the CI was wider (RR 1.16, 85% CI 0.89-1.50). There was a borderline trend of increasing CBC risk with longer duration of drinking, but the trend was attenuated after adjustment (p trend 5 0.10). There was no evidence for increased risk associated with either early initiation of drinking or, in WECARE II, with increasing amount consumed. Compared to never smoking, current, but not former, smoking was also associated with CBC risk (RR 1.23, 95% CI 1.01-1.51) ( Table  3 ). Age at smoking initiation, duration or average amount smoked were not statistically significantly associated with CBC risk; however, compared to never smokers, women at or above the median for pack-years were at a significantly increased risk of CBC that was only slightly attenuated after full adjustment (RR 1.28, 95% CI 0.98-1.67). When considered together, any history of both drinking and smoking at or before first breast cancer, but not either in isolation, was associated with a significantly increased risk of CBC compared to never drinking or smoking (RR 1.24, 95% CI 1.01-1.52) ( Table 4 ). This risk was greater in women who were drinking and smoking at the time of initial breast cancer diagnosis, even after adjustment for multiple factors (RR 1.62, 95% CI 1.24-2.11). The interaction between current drinking and smoking was statistically significant (p 5 0.008) whereas the interaction between any drinking and smoking history was not (p-0.76).
Following a first breast cancer diagnosis, there was only marginal evidence that drinking or smoking during the period prior to the reference date was associated with an increased risk of CBC compared to no drinking or no smoking during this period (RR 1.15, 95% CI 0.98-1.34 and RR 1.20, 95% CI 0.99-1.46, respectively) ( Tables 2 and 3 ). There was no evidence of a dose-response with increasing intake of alcohol (Table 2 ), but women who smoked at least 10 cigarettes per day were at statistically significantly greater risk compared to non-smokers (RR 1.50, 95% CI 1.08-2.08) ( Table 3 ). When considered in combination a statistically significant increase in risk was only observed in women who both drank and smoked during this period compared to those who did neither (RR 1.54, 95% CI 1.18-1.99) (Table 4 ), similar to current intake at diagnosis.
We also examined drinking and smoking status at and after first diagnosis, separately and combined, in each WECARE Study phase and results were generally similar (data not shown). Cases and controls were matched on reporting registry and subgroup analyses examining heterogeneity of results by country did not indicate any evidence for differences (data not shown). Most study participants (71% of CBC cases and 72% of UBC controls) were from the United States. In addition, we considered potential heterogeneity in findings by the ER status of the first breast cancer diagnosis, but found no evidence for interaction with p-values ranging from 0.26 to 0.83. There was no evidence for interaction between smoking history at first breast cancer diagnosis and first-degree family history of breast cancer (p 5 0.69), but the interaction between drinking history and family 1 The reference date for cases was the CBC diagnosis date while for controls it was defined by adding the interval between the first breast cancer and the CBC for the matched case to the date of breast cancer for the control. 2 Note that two centres (Los Angeles County and Orange and San Diego Counties) only participated in the WECARE I Study where control to case matching was 2:1 and two sites only participated in the WECARE II Study (Northern California and Ontario, Canada) where the matching ratio was 1:1 and the range of years of diagnosis in the two phases differed, although with considerable overlap. 3 Therapy for first diagnosis or recurrence prior to reference date. 4 The differences in radiation therapy between groups are due to the design of the WECARE I Study where there was counter-matching based on radiation therapy.
history did reach statistical significance (p 5 0.04). The increased risk of CBC associated with current drinking at first breast cancer diagnosis was only observed in women without a family history (RR 5 1.41, 95% CI 1.10-1.82 in women without a family history vs. RR 5 0.85, 96% CI 0.42-1.69 in women with a family history). 1 Adjusted for age at first diagnosis. 2 Adjusted for age at first diagnosis, first degree family history of breast cancer, body mass index at first diagnosis, age at menarche, number of full term pregnancies, first diagnosis histology, first stage, first diagnosis estrogen receptor status, chemotherapy, radiation and hormone therapy for breast cancer prior to the reference date, and ever smoking (or ever smoking after 1st diagnosis). 3 In the WECARE II Study only, averaged over periods of drinking. 4 Average number of drinks per week x duration of drinking, median 5 2,818, range 24-107,018. 5 Up to the reference date (for cases this was the CBC diagnosis date while for controls it was defined by adding the interval between the first breast cancer and the CBC for the matched case to the date of breast cancer for the control).
Discussion
At the time of an initial diagnosis of breast cancer, information on drinking and active smoking may contribute to the prediction of risk of developing a CBC. Consumption of both alcohol and tobacco at the time of first diagnosis had the strongest association with increased CBC risk among all the drinking and smoking variables considered and may be a useful addition to risk prediction models, particularly as this 1 Adjusted for age at first diagnosis. 2 Adjusted for age at first diagnosis, first degree family history of breast cancer, body mass index at first diagnosis, age at menarche, number of full term pregnancies, first diagnosis histology, first diagnosis stage, first diagnosis estrogen receptor status, chemotherapy, radiation and hormone therapy for breast cancer prior to the reference date, and ever drinking (or ever drinking after 1st diagnosis). 3 In the WECARE II Study only, averaged over periods of smoking. 4 Average number of cigarettes per day/20 3 duration of smoking, median 5 3,579, range 5-27,759. 5 Up to the reference date (for cases this was the CBC diagnosis date while for controls it was defined by adding the interval between the first breast cancer and the CBC for the matched case to the date of breast cancer for the control).
information is relatively easy to collect. The combination of both drinking and smoking following a first diagnosis was also associated with increased CBC risk and suggests that lifestyle interventions may be beneficial in this group. Alcohol is a well-established modest risk factor for first primary breast cancer, although the role of timing of exposure remains unclear. 5, 6 The data on smoking as a risk factor for first primary breast cancer have been inconsistent and controversial, but the weight of evidence now suggests that active smoking is also a modest risk factor. 7 Earlier studies with smaller sample sizes and often limited information on the exposures of interest did not find associations between either alcohol consumption or smoking and CBC risk. 11 In our previous analysis of WECARE I, we found evidence of increased risk of CBC among ever drinkers and also an increase in risk with increasing lifetime duration of drinking, but little evidence of an association with smoking.
12
To our knowledge only one other study, in older, ERpositive women only, separately considered smoking and drinking history specifically at and after an initial breast cancer diagnosis. 13 Although their variable definitions differed somewhat from ours, the evidence for some association between any drinking prior to a first breast cancer diagnosis appears consistent between the two studies and both studies observed increased CBC risk with smoking at first diagnosis and subsequent smoking. In our much larger study, we were able to estimate the risks relative to not drinking and smoking more precisely. Furthermore, our findings did not differ by ER status at first diagnosis. Li et al. also evaluated CBC risk associated with drinking and smoking in combination and observed greatly elevated risk of CBC among women who were in the highest alcohol consumption category and were current smokers either at the time of first diagnosis or at the reference date. 13 Those estimates, although imprecise and likely somewhat inflated, are consistent with the increased CBC risk we observed for drinking and smoking in combination. Our estimates of increased risk are lower, but more precise. In both studies, the levels of drinking were quite modest with most women consuming less than one drink per day.
Both alcohol drinking and cigarette smoking are plausible risk factors for breast cancer. Several mechanisms have been proposed to explain the association of alcohol with first primary breast cancer 5 and carcinogens in cigarettes are well documented. 7 The bulk of evidence suggests that both alcohol drinking and cigarette smoking are relatively weak risk factors, but do contribute to breast cancer risk. 5, 7 It is possible that engaging in both behaviours may also be a marker of other unhealthy lifestyle factors, such as poor diet and physical inactivity, that explain or enhance the association of 1 Adjusted for age at first diagnosis. 2 Adjusted for age at first diagnosis, breast cancer family history, body mass index at first diagnosis, age at menarche, number of full term pregnancies, first diagnosis histology, first diagnosis stage, first diagnosis estrogen receptor status, chemotherapy for first diagnosis, radiation for first diagnosis, hormone therapy for first diagnosis. 3 Up to the reference date (for cases this was the CBC diagnosis date while for controls it was defined by adding the interval between the first breast cancer and the CBC for the matched case to the date of breast cancer for the control).
drinking and smoking in combination with CBC risk. In either case, women who both drink and smoke at diagnosis or who continue to engage in both behaviours following a breast cancer diagnosis may represent a group who would benefit from enhanced support for lifestyle modification. However, we note that few women in our study reported stopping smoking or drinking around the time of a first breast cancer diagnosis in the WECARE Study and few in the WECARE II Study reported a reduction in the amount consumed after first diagnosis. Therefore, we cannot assess any potential effect of these changes. Our study has several important strengths. With 1,521 CBC cases, the size of the study is far larger than any other on this topic. In addition, we could account for many important covariates in the analysis through our collection of detailed information from medical records and from the study participants. Nonetheless, there are some study limitations. We only collected detailed information on lifetime drinking and smoking in the WECARE II Study and thus had a more restricted sample size for these analyses. The study population was restricted to women younger than 55 years at the first breast cancer diagnosis and results may differ in older women. We note, however, that younger women have a higher risk of developing CBC than older women. Case-control studies always have the potential for recall bias in self-reported behaviours, but this is mitigated in our design as both the CBC cases and UBC controls had a diagnosis of breast cancer and matched cases and controls had a similar recall period. Some non-differential recall error is likely, leading to attenuation in results, although ever drinking or smoking and continuing to drink and/or smoke after diagnosis are likely recalled with some accuracy. Few women in the study reported heavy drinking and, consequently, we cannot comment on risks associated with high alcohol consumption. Despite the depth and breadth of our data, there was some information we did not collect and, therefore, we could not evaluate or adjust for other health behaviours such as diet. We also did not collect information on passive smoking. Although the role of second hand smoking is less clear than active smoking, 7 this may have attenuated the estimates of the effect of active smoking. In summary, in our large combined WECARE I and WECARE II Studies we found evidence that current drinking and smoking in combination at the time of a first breast cancer is a marker of increased risk of CBC. In addition, women who both drink and smoke following diagnosis continue to be at increased risk. Although the relative increase in CBC risk is not high, given the background risk of CBC and concern regarding this risk, lifestyle interventions may be warranted in this group.
